-
PP 1: A Mechanistic Map of Src Signaling
2026-09-10
PP 1, a Src family tyrosine kinase inhibitor, can separate kinase-dependent phosphorylation from metabolic vulnerabilities in cancer and immune models. This article explains how to interpret Lck, Fyn, Lyn, RET, and EDI3-related experiments without conflating biochemical potency with disease-specific efficacy.
-
L. reuteri FN041 Reshapes Colitis Microbiota
2026-09-10
This mouse study identifies human milk-derived Limosilactobacillus reuteri FN041 as a potential modulator of DSS-induced colitis through coordinated changes in intestinal inflammation, barrier integrity, gut microbiota, and metabolites. Its main contribution is a multi-omics view of probiotic activity, while its findings remain preclinical and require validation in controlled mechanistic and clinical studies.
-
CX-4945 (Silmitasertib): A CK2 Assay Playbook
2026-09-09
CX-4945 (Silmitasertib) is a selective CK2 inhibitor for dissecting kinase-dependent signaling, apoptosis, and cell-cycle control. This assay-focused guide connects oncology evidence with the CK2–CIAV host-dependency study while clarifying translational limits.
-
Perphenazine: D2 Antagonist Research Workflows
2026-09-09
Perphenazine supports receptor pharmacology, mitochondrial stress, opioid tolerance suppression, and host-directed antibacterial assays in one adaptable research workflow. This guide separates established findings from practical optimization recommendations so teams can design more reproducible neuropharmacology and macrophage experiments.
-
Rotigotine hydrochloride: Applied Research Workflows
2026-09-08
Build more interpretable Parkinson’s disease and depression-model experiments with a dopamine D2/D3 receptor agonist designed for dose, route, and behavioral readout comparisons. This guide translates rotigotine pharmacology into practical cell-based, rodent, formulation, and troubleshooting workflows.
-
MK0787 vs. β-Lactam Antibiotics in Resistant Bacteria
2026-09-08
The 1982 study by Cullmann and colleagues benchmarked N-formimidoyl thienamycin (MK0787) against several newer β-lactam antibiotics across resistant gram-negative and gram-positive clinical isolates. Its main contribution was to combine broad-spectrum MIC comparisons with bactericidal and β-lactamase-related analyses, providing a useful historical framework for antibiotic resistance research and comparative antibacterial activity assays.
-
Bacitracin (B1670): Practical Research Guide
2026-09-07
Bacitracin (B1670) is a peptide antibiotic for controlled antibacterial research involving bacterial cell wall and peptidoglycan synthesis. This guide explains preparation, storage, controls, and troubleshooting while emphasizing that the product is for scientific research only, not diagnostic or medical use.
-
AEBSF.HCl: An Orthogonal Lens on Protease Biology
2026-09-05
AEBSF.HCl can help translational researchers separate serine-protease effects from cathepsin-driven necroptosis, while extending mechanistic thinking into amyloid and cell-lysis models. This article links the reagent’s irreversible chemistry to experimental design, evidence boundaries, and strategic validation.
-
Perphenazine: D2 Antagonist Research Workflows
2026-09-05
Perphenazine supports a versatile research workflow spanning dopamine signaling, mitochondria-mediated cell death induction, opioid tolerance suppression, and host-directed antibacterial studies. This guide connects receptor pharmacology with practical cell-based assay design, solution handling, controls, and troubleshooting.
-
PBS Liposomes: Controls for TRPM3 Studies
2026-09-04
PBS Liposomes provide a mechanistically informative control for separating macrophage uptake from clodronate-mediated depletion. This guide connects K2722 control logic with structural and functional lessons from TRPM3 research while defining practical limits for neuroimmunology workflows.
-
SARS-CoV-2 N Protein Rewires GADD34 Stress Foci
2026-09-04
The reference study identifies a mechanism by which SARS-CoV-2 nucleocapsid protein sequesters GADD34 mRNA in atypical G3BP1-positive foci, weakening IRF3 nuclear signaling and innate antiviral defense. Its findings connect stress-granule biology with mRNA localization and interferon regulation, while suggesting experimental priorities for studying viral immune antagonism.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-03
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids that combine matched tumor organoids with tumor-derived stromal subpopulations. The model captures clinically relevant tumor–stroma effects on gene expression and drug sensitivity, providing a more informative platform for resistance studies and personalized therapeutic screening.
-
EZ Cap™ Mouse IL-12 mRNA Workflow Guide
2026-09-03
Build more controlled mouse IL-12 expression studies with a capped, polyadenylated, m1Ψ-modified transcript designed for efficient translation and reduced innate immune activation. This guide connects practical cell-based workflows with emerging extrahepatic delivery strategies for immunotherapy research mRNA.
-
Perphenazine (B6157): Reliable Cell Assays
2026-09-02
Perphenazine (SKU B6157) offers a practical, mechanism-informed option for cell viability, neuropharmacology, and host-directed infection studies. This scenario-based guide covers solvent compatibility, dose and time-point selection, mitochondrial readouts, data interpretation, and research-supplier evaluation.
-
GANT61 in ALK-Positive ALCL: Hh–PIK3IP1–Akt Axis
2026-09-02
A 2026 study identifies a potential signaling connection between Hedgehog transcriptional activity, the PI3K inhibitor PIK3IP1, and Akt phosphorylation in ALK-positive anaplastic large cell lymphoma. GANT61 inhibited proliferation, altered cell-cycle progression, and increased apoptosis in ALK-positive ALCL models, supporting further investigation of Gli1-directed strategies while leaving important questions about specificity and clinical translation unresolved.